1. Jones RN: Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY Antimicrobial Surveillance Program (1997-2001). Semin Respir Crit Care Med. 2003;24(1):121-134
2. O’NEILL CBJ: TACKLING DRUG-RESISTANT INFECTIONS GLOBALLY: FINAL REPORT AND RECOMMENDATIONS. 2016; https://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf, 2022
3. Årdal C, Outterson K, Hoffman SJ, et al: International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016;387(10015):296-307
4. 国際的に脅威となる感染症対策関係閣僚会議. 薬剤耐性(AMR)対策アクションプラン. http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000- Kenkoukyoku/0000120769.pdf. Accessed Sep, 30th 2021, 2018
5. 具 芳, 藤友 結, 添田 博, et al: 全国の診療所医師を対象とした抗菌薬適正使用に関するアンケート調査. 感染症学雑誌. 2019;93(3):289-297
6. Muraki Y, Yagi T, Tsuji Y, et al: Japanese antimicrobial consumption surveillance: First report on oral and parenteral antimicrobial consumption in Japan (2009-2013). J Glob Antimicrob Resist. 2016;7:19-23.
7. Yamasaki D, Tanabe M, Muraki Y, et al: The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group. Infection. 2018;46(2):207-214
8. Sanchez GV, Fleming-Dutra KE, Roberts RM, et al: Core Elements of Outpatient Antibiotic Stewardship. MMWR Recomm Rep. 2016;65(6):1-12
9. SURVEILLANCE REPORT : Antimicrobial resistance surveillance in Europe 2012. 2012; https://www.ecdc.europa.eu/sites/default/files/media/en/publications/ Publications/antimicrobial-resistance-surveillance-europe-2012.pdf
10. Hsia Y, Sharland M, Jackson C, et al: Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. The Lancet Infectious diseases. 2019;19(1):67-75
11. Goossens H, Ferech M, Vander Stichele R, et al: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579-587.
12. 宮入 烈. 小児科領域におけるこれからの薬剤耐性菌(AMR)対策. 日本化学療法学会雑誌. 2019;67(4):446-451
13. Monto AS. Studies of the community and family: acute respiratory illness and infection. Epidemiol Rev. 1994;16(2):351-373
14. Kinoshita N, Morisaki N, Uda K, et al: Nationwide study of outpatient oral antimicrobial utilization patterns for children in Japan (2013- 2016). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019;25(1):22-27
15. Uda K, Okubo Y, Kinoshita N, et al: Nationwide survey of indications for oral antimicrobial prescription for pediatric patients from 2013 to 2016 in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019;25(10):758-763
16. Muraki Y, Kusama Y, Tanabe M, et al: Impact of antimicrobial stewardship fee on prescribing for Japanese pediatric patients with upper respiratory infections. BMC health services research. 2020;20(1):399
17. Kinoshita N, Komura M, Tsuzuki S, et al: The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2020;26(6):582-587
18. Ikegami N, Yoo BK, Hashimoto H, et al: Japanese universal health coverage: evolution, achievements, and challenges. Lancet. 2011;378(9796):1106-1115
19. Fujimori K. Current Status and Issues of the National Database. 2016;26.
20. 総務省統計局 人口推計. https://www.e-stat.go.jp/stat- search/database?page=1&toukei=00200524&result_page=1. Accessed 30th sep, 2021
21. WHO Collaborating Center for Drug Statistics Methodology. https://www.whocc.no/. Accessed 9th January, 2022
22. Uda K, Kinoshita N, Morisaki N, et al: Targets for Optimizing Oral Antibiotic Prescriptions for Pediatric Outpatients in Japan. Japanese journal of infectious diseases. 2019;72(3):149-159
23. 全国保険医療機関（病院・診療所）一覧. 2021; https://www.ihep.jp. Accessed 30th sep,2021, 2021
24. 二木 芳, 賀来 満, 青木 洋, et al: 抗菌薬適正使用支援プログラム実践のためのガイダンス. 日本臨床微生物学雑誌. 2017;27(4):227-266
25. Antimicrobial Use and Resistance (AUR) Module https://www.cdc.gov/nhsn/pdfs/pscmanual/11pscaurcurrent.pdf. Accessed 9th January, 2022
26. Barlam TF, Cosgrove SE, Abbo LM, et al: Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016;62(10):e51-77
27. Ibrahim OM, Polk RE: Antimicrobial use metrics and benchmarking to improve stewardship outcomes: methodology, opportunities, and challenges. Infect Dis Clin North Am. 2014;28(2):195-214
28. 抗菌薬使用量集計マニュアル ver1.1. https://amrcrc.ncgm.go.jp/050/pdf/20190116AMUmanual.pdf. Accessed 9th Jan, 2022
29. Holstiege J, Schink T, Molokhia M, et al: Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study. BMC Pediatr. 2014;14:174
30. Chai G, Governale L, McMahon AW, et al: Trends of outpatient prescription drug utilization in US children, 2002-2010. Pediatrics. 2012;130(1):23-31
31. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Archives of disease in childhood. 2011;96(6):590-595
32. Hawker JI, Smith S, Smith GE, et al: Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995- 2011: analysis of a large database of primary care consultations. The Journal of antimicrobial chemotherapy. 2014;69(12):3423-3430
33. Lee GC, Reveles KR, Attridge RT, et al: Outpatient antibiotic prescribing in the United States: 2000 to 2010. BMC medicine. 2014;12:96
34. Okubo Y, Nariai H, Michels KB, et al: Change in clinical practice variations for antibiotic prescriptions across different pediatric clinics: A Japan's nationwide observational study. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2021
35. Brauer R, Ruigómez A, Downey G, et al: Prevalence of antibiotic use: a comparison across various European health care data sources. Pharmacoepidemiology and drug safety. 2016;25 Suppl 1(Suppl Suppl 1):11-20
36. Kinoshita N, Morisaki N, Uda K, et al: Nationwide study of outpatient oral antimicrobial utilization patterns for children in Japan (2013- 2016). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2019;25(1):22-27
37. Norio Ohmagari MD, M.Sc., Ph.D. Shingaku Kaneko, M.T.Takashi Kitahara, Ph.D. et al: Manual of Antimicrobial Stewardship (1st Edition). 2017; http://www.mhlw.go.jp/file/06-Seisakujouhou-10900000- Kenkoukyoku/0000193504.pdf. Accessed 14,April, 2018
38. Heikkinen T, Jarvinen A. The common cold. Lancet. 2003;361(9351):51-59
39. The fiscal year 2018 Revision of Reimbursement of Medical Fees. 2018; https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000188411.html.
40. King LM, Bartoces M, Fleming-Dutra KE, et al: Changes in US Outpatient Antibiotic Prescriptions From 2011-2016. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020;70(3):370-377
41. 重症型のレンサ球菌・肺炎球菌感染症に対するサーベイランスの構築と病因解析、その診断・治療に関する研究.http://strep.umin.jp/breakingnews/pneumococcus.html. Accessed 9th Jan, 2022.
42. 累積予防接種率調査. 2018; 2018/4/11:https://www.niid.go.jp/niid/ja/vaccine-j/7956-cum-vaccine- coverage. Accessed 9th Jan, 2022
43. Current situation of invasive pneumococcal disease among children following the introduction of 13-valent pneumococcal conjugate vaccine. 2017; https://www.niid.go.jp/niid/en/iasr-e.html. Accessed 5th september, 2021
44. Naito S, Tanaka J, Nagashima K, et al: The impact of heptavalent pneumococcal conjugate vaccine on the incidence of childhood community-acquired pneumonia and bacteriologically confirmed pneumococcal pneumonia in Japan. Epidemiology and infection. 2016;144(3):494-506
45. Howitz MF, Harboe ZB, Ingels H, et al: A nationwide study on the impact of pneumococcal conjugate vaccination on antibiotic use and ventilation tube insertion in Denmark 2000-2014. Vaccine. 2017;35(43):5858-5863
46. Kimura Y, Fukuda H, Hayakawa K, et al. Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non- bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017. PloS one. 2019;14(10):e0223835
47. 林 伸. 顔面の尋常性ざ瘡治療における外用・内服抗菌薬の処方に関する医師へのアンケート及びカルテ情報を基にした実態調査. 日本臨床皮膚科医会雑誌. 2020;37(3):424-433
48. Molstad S, Lofmark S, Carlin K, et al: Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bulletin of the World Health Organization. 2017;95(11):764-773
49. Maeda M, Muraki Y, Kosaka T, et al: Impact of health policy on structural requisites for antimicrobial stewardship: A nationwide survey conducted in Japanese hospitals after enforcing the revised reimbursement system for antimicrobial stewardship programs. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2021;27(1):1-6
50. Kato T, Tanaka I, Seyama Y, et al: The effectiveness of prescription support and treatment reporting system on the appropriate usage of oral third-generation cephalosporins. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2021;27(3):419-423
51. Madaras-Kelly K, Hostler C, Townsend M, et al: Impact of Implementation of the Core Elements of Outpatient Antibiotic Stewardship Within Veterans Health Administration Emergency Departments and Primary Care Clinics on Antibiotic Prescribing and Patient Outcomes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021;73(5):e1126-e1134
52. Wise J: Hospitals and GPs are offered incentives to reduce antibiotic prescribing. BMJ : British Medical Journal. 2016;352:i1499
53. Bou-Antoun S, Costelloe C, Honeyford K, et al: Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotics in the community: an interrupted time series analysis. The Journal of antimicrobial chemotherapy. 2018;73(10):2883-2892
54. Nyquist AC, Gonzales R, Steiner JF, et al: Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. Jama. 1998;279(11):875-877
55. Kozyrskyj A, Klassen TP, Moffatt M, et al: Short-course antibiotics for acute otitis media. The Cochrane database of systematic reviews. 2010;2010(9):Cd001095
56. Hoberman A, Paradise JL, Rockette HE, et al: Shortened Antimicrobial Treatment for Acute Otitis Media in Young Children. The New England journal of medicine. 2016;375(25):2446-2456
57. Hayashi N, Akamatsu H, Iwatsuki K, et al: Japanese Dermatological Association Guidelines: Guidelines for the treatment of acne vulgaris 2017. The Journal of dermatology. 2018;45(8):898-935
58. Shiro H, Sato Y, Toyonaga Y, et al: Nationwide survey of the development of drug resistance in the pediatric field in 2000-2001, 2004, 2007, 2010, and 2012: evaluation of the changes in drug sensitivity of Haemophilus influenzae and patients' background factors. Journal of infection and chemotherapy . 2015;21(4):247-256
59. Eady EA, Gloor M, Leyden JJ: Propionibacterium acnes resistance: a worldwide problem. Dermatology. 2003;206(1):54-56
60. Suaya JA, Gessner BD, Fung S, et al: Acute otitis media, antimicrobial prescriptions and medical expenses among children in the United States during 2011-2016. Vaccine. 2018;36(49):7479-7486
61. Yamaguchi S, Matsubayashi K, Mizuno K, at al: First-line antibiotic prescription patterns for acute otitis media in children: A descriptive study using Japanese claims data (2014-2018). Journal of infection and chemotherapy. 2021;27(9):1300-1305
62. 宮入烈ら. 小児における感染症対策に係る地域ネットワークの標準モデルを検証し全国に普及するための研究. 2019; https://mhlw-grants.niph.go.jp/project/27951
論文の公開元へ
